Health Industry News
Women encouraged to check their heart health
The classical image of a heart attack is that of a man battling to breathe, crippled in pain. However new research published in British Medical Journal, Heart, on March 1, 2017, reveals Australian women are less likely to be screened for heart disease than men. The new research, entitled, Gender inequalities in cardiovascular risk factor…
Read MoreThousands of Pharmacists Gather in Queensland for Annual Australian Pharmacy Professional Conference
Today marks the start of the annual Australian Pharmacy Professional Conference (APP 2017) where thousands for pharmacy and healthcare professionals are gathering to discuss the latest developments in the health industry. Top international speakers include Alistair Bursey, owner-pharmacist and Chair of the Board of Canadian Pharmacists Association (CPHA); and Graeme Blanchard, President of the…
Read MoreAPP gearing up to announce Guild Pharmacy of the Year for 2017
The Pharmacy Guild of Australia is gearing up for their national conference, set for March 9-12, 2017 on the Gold Coast. With more than 70 presentations from local and international speakers, the conference is the major highlight of the annual Australian pharmacy calendar. Federal Health Minister, The Hon. Greg Hunt MP will deliver the conference…
Read MoreNew advisory council for Medicines Australia – March 6, 2017
Medicines Australia (MA) has today (March 6, 2017) announced the appointment of 10 members to its new advisory council. Dr Anna Lavelle will act as MA Chair, and will be joined by ex-Chief Scientist of Australia, Professor Ian Chubb AC, Dr Jeff Harmer who has held many senior roles in various Commonwealth departments, and a…
Read MoreNew hep C treatments make disease elimination a possibility by 2026 in Australia
Australia is on track to achieve hepatitis C (hep C) elimination within 10 years, having treated more than 30,000 people in 2016.1 This is according to a new report1, released today (February 21, 2017), which coincides with the availability of the latest hep C treatment, ZEPATIER® (elbasvir/grazoprevir), on the Pharmaceutical Benefits Scheme (PBS).2 The…
Read More